Evidence map›Paper›PMID 22474354›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Morphine activates neuroinflammation in a manner parallel to endotoxin.

Xiaohui Wang, Lisa C Loram, Khara Ramos, Armando J de Jesus, Jacob Thomas, Kui Cheng, Anireddy Reddy, Andrew A Somogyi, Mark R Hutchinson, Linda R Watkins and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 270 papers.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 503 citations in OpenAlex.

  1. Article
  2. Article
  3. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Xiaohui WangDepartment of Chemistry and Biochemistry, Center for Neuroscience, and Biofrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.
Lisa C Loram
Khara Ramos
Armando J de Jesus
Jacob Thomas
Kui Cheng
Anireddy Reddy
Andrew A Somogyi
Mark R Hutchinson
Linda R Watkins
Hang Yin
Center for Neurosciences · USUniversity of Adelaide · AUUniversity of Colorado Boulder · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod ActionsR01DA023132 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$1.9M
Immune and Gilia Regulation of Pain & Analgesic ActionsK05DA024044 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$616k
Developing Small-Molecule Probes for Opioid-Induced Glial ActivationR21NS067425 · NINDS · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$452k
Transforming Clinical Pain Control by Targeting a Novel Non-Neuronal ReceptorR03DA025740 · NIDA · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$379k
Optimizing the Clinical Efficacy of Opioids by TLR4 BlockadeR21DA026950 · NIDA · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$273k
NCRR NIH HHS RR025780NCRR NIH HHS UL1 RR025780NIDA NIH HHS DA023132NIDA NIH HHS DA024044NIDA NIH HHS DA025740NIDA NIH HHS DA026950NIDA NIH HHS DA029119NIDA NIH HHS K05 DA024044NIDA NIH HHS R01 DA023132NIDA NIH HHS R03 DA025740NIDA NIH HHS R21 DA026950NINDS NIH HHS NS067425NINDS NIH HHS R21 NS067425
6 · The paper itself

Abstract

Opioids create a neuroinflammatory response within the CNS, compromising opioid-induced analgesia and contributing to various unwanted actions. How this occurs is unknown but has been assumed to be via classic opioid receptors. Herein, we provide direct evidence that morphine creates neuroinflammation via the activation of an innate immune receptor and not via classic opioid receptors. We demonstrate that morphine binds to an accessory protein of Toll-like receptor 4 (TLR4), myeloid differentiation protein 2 (MD-2), thereby inducing TLR4 oligomerization and triggering proinflammation. Small-molecule inhibitors, RNA interference, and genetic knockout validate the TLR4/MD-2 complex as a feasible target for beneficially modifying morphine actions. Disrupting TLR4/MD-2 protein-protein association potentiated morphine analgesia in vivo and abolished morphine-induced proinflammation in vitro, the latter demonstrating that morphine-induced proinflammation only depends on TLR4, despite the presence of opioid receptors. These results provide an exciting, nonconventional avenue to improving the clinical efficacy of opioids.

Indexed as

Analgesics, OpioidAnimalsBlotting, WesternCell LineDimerizationEndotoxinsFemaleHEK293 CellsHumansInterleukin-1betaLymphocyte Antigen 96MaleMiceMice, Inbred BALB CMice, KnockoutModels, MolecularAnalgesics, OpioidEndotoxinsInterleukin-1betaLymphocyte Antigen 96MorphineToll-Like Receptor 4

Identifiers

PMID22474354
PMCPMC3341002
OpenAlexW1988795126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.